Unknown PHASE1 INTERVENTIONAL NCT00377897

Cell Therapy With Bone Marrow Mononuclear Cells in Critical Leg Ischemia (CLI)

Optimisation d'un Produit de thérapie Cellulaire Autologue Par Cellules mononucléées médullaires Dans l'ischémie Critique Des Membres inférieurs liée à l'athérosclérose

Sponsor: Assistance Publique - Hôpitaux de Paris

Conditions Critical Leg Ischemia

Interventions cell therapy

Updated 5 times since 2017 Last updated: Feb 13, 2009 Started: Jan 31, 2005 Primary completion: Sep 30, 2008 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00377897, this PHASE1 trial focuses on Critical Leg Ischemia and remains ongoing. Sponsored by Assistance Publique - Hôpitaux de Paris, it has been updated 5 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique - Hôpitaux de Paris
University of Paris 5 - Rene Descartes

Data source: University of Paris 5 - Rene Descartes

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France